RetiSpec Announces Partnership With Gentex To Commercialize Alzheimer's Disease Detection Technology

"The Gentex-RetiSpec partnership reinforces our commitment to bring to market RetiSpec's novel retinal imaging technology, a widely scalable and affordable way to accurately detect Alzheimer's Disease at both the symptomatic and pre-symptomatic stages," said Eliav Shaked, CEO of RetiSpec.


1 view0 comments